Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Fear, misinformation and outdated attitudes lead many pregnant women to park their running shoes, but the latest science and ...

Stay healthy this flu season. Learn about the CDC’s recommendations for annual influenza vaccinations and how to protect your ...

A new law will go into effect in Louisiana on Oct. 1 that will classify two drugs—mifepristone and misoprostol, which are ...

A new model, TxGNN, revolutionizes zero-shot drug repurposing by predicting treatments for diseases with no known therapies, ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

Lawmakers passed a law designed to limit reproductive rights in Louisiana. But it may also limit patients’ chances of ...

AI tool TxGNN identifies existing drugs as potential treatments for over 17,000 rare diseases, promising faster, ...

TxGNN is the first AI model specifically developed to identify drug candidates for rare diseases and conditions with no ...

This approach to drug repurposing is haphazard at best. It relies on patient reports of unexpected beneficial side effects or ...

There are more than 7,000 rare and undiagnosed diseases globally. Although each condition occurs in a small number of ...